Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-052503
Filing Date
2025-04-09
Accepted
2025-04-09 16:06:26
Documents
29
Period of Report
2025-04-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A tennx-20250409.htm   iXBRL PRE 14A 1098484
2 GRAPHIC img179895284_0.jpg GRAPHIC 10268
3 GRAPHIC img179895284_1.jpg GRAPHIC 688
4 GRAPHIC img179895284_2.jpg GRAPHIC 702
5 GRAPHIC img179895284_3.jpg GRAPHIC 688
6 GRAPHIC img179895284_4.jpg GRAPHIC 688
7 GRAPHIC img179895284_5.jpg GRAPHIC 688
8 GRAPHIC img179895284_6.jpg GRAPHIC 702
9 GRAPHIC img179895284_7.jpg GRAPHIC 688
10 GRAPHIC img179895284_8.jpg GRAPHIC 702
11 GRAPHIC img179895284_9.jpg GRAPHIC 688
12 GRAPHIC img179895284_10.jpg GRAPHIC 702
13 GRAPHIC img179895284_11.jpg GRAPHIC 688
14 GRAPHIC img179895284_12.jpg GRAPHIC 286840
15 GRAPHIC img179895284_13.jpg GRAPHIC 603254
16 GRAPHIC img179895284_14.jpg GRAPHIC 372730
  Complete submission text file 0000950170-25-052503.txt   5100616

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tennx-20250409.xsd EX-101.SCH 7796
31 EXTRACTED XBRL INSTANCE DOCUMENT tennx-20250409_htm.xml XML 417882
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34600 | Film No.: 25825248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)